AbbVie Partnering Day

Redwood City, CA


AbbVie has the expertise of a proven pharmaceutical leader and the focus and passion of a biotech. The result is something rare in health care today – a global biopharmaceutical company that has the ability to discover and advance innovative therapies and meet the health needs of people and societies around the globe. AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories, Inc.

AbbVie partnerships are dedicated to two important outcomes: developing innovative new medicines and delivering a remarkable impact on peoples’ lives. AbbVie takes a highly strategic approach to developing these partnerships with a goal to create long-term mutually beneficial relationships. A passion for translating science into effective medicine and a shared vision for a successful outcome are important foundations for AbbVie partnerships.

This AbbVie Partnering Day is focused on a core set of therapeutic areas where the company has proven expertise and where AbbVie believes it can have an even greater impact on the disease and how it is managed.

Areas Of Interest
New Formulations & Technologies

  • Henry Gosebruch
    Executive Vice President, Chief Strategy Officer
  • Scott Brun
    Vice President, AbbVie Ventures
  • Jay Stamatis
    Vice President, Business Development & Acquisitions
  • Anna Maroney
    Vice President, Alliance Management
  • Erik von Borcke
    President, Pharmacyclics
  • Kevin Lynch
    Vice President, Scientific Assessment
  • Tom Hudson
    Vice President, Oncology, Discovery, Early Development
  • Anil Singhal
    Vice President, Oncology, Early Development, Redwood City Site Head

AbbVie Partnering Day


March 28, 2017

9:00 am – 3:15 pm
One-on-One Meetings*
Location: Junior Boardroom, Room 330, Salons 3,4,6,7

3:30 pm – 5:00 pm
Plenary Session
Location: Blue Room

5:00 pm – 7:00 pm
General Networking Reception
Location: Veranda


Pullman San Francisco Bay
223 Twin Dolphin Dr, Redwood City, CA 94065


Parking available on-site


Application is required for one-on-one meetings. Only companies reviewed and approved will be scheduled for  one-on-one partnering meeting. Application review is on a rolling basis, so we suggest applying early due to a limited number of available appointments.

Apply for One-on-One Meeting

The AbbVie Plenary Session followed by a Networking Reception is open to the general public. If you are interested in attending, please register below. Attendance to the Plenary Session does not guarantee a private one-on-one meeting with the AbbVie Team. For a private meeting, please submit the application above. Only companies reviewed and approved will be scheduled for a one-on-one partnering meeting.

Due to high demand, the Plenary/Reception is now restricted to employees of bioscience companies only.

Attire:Business attire suggested
  • Early registration is highly advised as space is limited and there will be no on-site registration
  • Pre-registered attendees will receive an immediate receipt/confirmation after submission
  • Please print this receipt/confirmation and bring it with you to receive your conference credentials
  • Photo ID (driver’s license or passport) will be required at check-in
  • All sales are final

Please mail your event-related questions to: or you can contact us via phone: 650-871-3257.

Is your company a member? Click here to check.